🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/07/2007 | 48,20 | 48,53 | 47,89 | 48,50 | -0,04% | 1,33% | 8.825.942 |
| 13/07/2007 | 48,23 | 48,79 | 48,16 | 48,52 | +0,16% | 1,31% | 10.625.567 |
| 12/07/2007 | 46,95 | 48,54 | 46,66 | 48,44 | +3,82% | 4,00% | 17.484.308 |
| 11/07/2007 | 46,28 | 46,90 | 46,21 | 46,66 | +0,49% | 1,48% | 14.496.250 |
| 10/07/2007 | 46,77 | 47,26 | 46,37 | 46,43 | -1,54% | 1,90% | 12.887.256 |
| 09/07/2007 | 47,23 | 47,30 | 46,79 | 47,16 | -0,08% | 1,07% | 9.621.059 |
| 06/07/2007 | 47,61 | 47,68 | 46,63 | 47,19 | -0,72% | 2,20% | 9.678.909 |
| 05/07/2007 | 47,42 | 47,61 | 47,10 | 47,54 | -0,02% | 1,07% | 8.491.106 |
| 03/07/2007 | 47,66 | 47,96 | 47,31 | 47,55 | +0,52% | 1,36% | 5.454.211 |
| 02/07/2007 | 47,62 | 48,00 | 46,97 | 47,30 | -0,46% | 2,16% | 13.771.768 |
| 29/06/2007 | 48,62 | 48,62 | 47,20 | 47,52 | -1,35% | 2,90% | 15.128.404 |
| 28/06/2007 | 48,27 | 48,76 | 47,98 | 48,17 | +0,30% | 1,62% | 13.367.659 |
| 27/06/2007 | 46,83 | 48,38 | 46,54 | 48,02 | +2,46% | 3,93% | 19.820.195 |
| 26/06/2007 | 46,21 | 47,46 | 46,18 | 46,87 | +1,61% | 2,77% | 16.883.385 |
| 25/06/2007 | 46,47 | 46,99 | 45,80 | 46,13 | -0,43% | 2,57% | 11.768.516 |
| 22/06/2007 | 46,68 | 47,14 | 46,05 | 46,33 | -1,52% | 2,33% | 15.201.240 |
| 21/06/2007 | 46,80 | 47,26 | 46,24 | 47,04 | +0,08% | 2,18% | 12.389.980 |
| 20/06/2007 | 47,71 | 47,80 | 46,96 | 47,00 | -2,11% | 1,76% | 14.710.776 |
| 19/06/2007 | 48,33 | 48,65 | 47,88 | 48,02 | -0,61% | 1,60% | 9.811.062 |
| 18/06/2007 | 48,57 | 48,66 | 47,99 | 48,31 | -0,20% | 1,39% | 7.820.595 |
| 15/06/2007 | 48,56 | 49,22 | 48,14 | 48,41 | +1,00% | 2,22% | 14.308.449 |
| 14/06/2007 | 48,33 | 48,33 | 47,81 | 47,93 | -0,87% | 1,09% | 10.972.979 |
| 13/06/2007 | 48,05 | 48,54 | 47,43 | 48,35 | +0,90% | 2,30% | 12.061.537 |
| 12/06/2007 | 48,35 | 48,71 | 47,91 | 47,92 | -1,63% | 1,66% | 11.830.767 |
| 11/06/2007 | 48,00 | 49,00 | 47,75 | 48,71 | +1,81% | 2,60% | 13.044.142 |
| 08/06/2007 | 48,00 | 48,18 | 47,36 | 47,84 | -0,40% | 1,71% | 11.885.473 |
| 07/06/2007 | 48,13 | 48,44 | 47,93 | 48,03 | -0,83% | 1,05% | 14.175.667 |
| 06/06/2007 | 48,66 | 48,96 | 48,32 | 48,44 | -1,32% | 1,31% | 12.255.102 |
| 05/06/2007 | 49,30 | 49,32 | 48,41 | 49,08 | -0,60% | 1,86% | 15.301.534 |
| 04/06/2007 | 49,67 | 49,67 | 49,04 | 49,38 | -0,75% | 1,27% | 15.318.826 |